Successful use of recombinant factor VIIa in a patient with acquired Glanzmann thrombasthenia
VIALLARD, Jean-Francois
Biologie des maladies cardiovasculaires = Biology of Cardiovascular Diseases
< Réduire
Biologie des maladies cardiovasculaires = Biology of Cardiovascular Diseases
Langue
EN
Article de revue
Ce document a été publié dans
Haemophilia. 2015-01, vol. 1, n° 1, p. 116–118
Résumé en anglais
NO ABSTRACT - Immune thrombocytopenic purpura (ITP) is caused by circulating antibodies that react with target antigens on the platelet membrane [1]. In very rare cases, ITP may be associated with acquired Glanzmann ...Lire la suite >
NO ABSTRACT - Immune thrombocytopenic purpura (ITP) is caused by circulating antibodies that react with target antigens on the platelet membrane [1]. In very rare cases, ITP may be associated with acquired Glanzmann thrombasthenia (GT), a severe bleeding disorder [2,3]. While congenital GT is caused by inherited mutations in the genes encoding a IIb or b3 subunits [4], acquired GT results from naturally occurring auto-antibodies directed against the a IIb b 3 complex, inhibiting its function. Patients classically present with thrombocytopenia and defective platelet aggregation in response to all physiological stimuli. ...< Réduire
Mots clés
Article CLINIQUE
Unités de recherche